Skip to main content
TOOLS
The Morningstar Fund Compare tool quickly evaluates different funds against one another. In addition to Nuveen funds, add any MF, CEF or ETF available from Morningstar. Important information and disclosures are included after you click Generate Report. Please ensure to enable pop-ups in your browser.
The Morningstar Portfolio Review tool compares and analyzes your portfolio holdings. In addition to Nuveen funds, add any MF, CEF or ETF available from Morningstar. Important information and disclosures are included after you click Generate Report. Please ensure to enable pop-ups in your browser.
utility-drawer__mobile-restriction Tools are currently unavailable for use on mobile. Please visit the desktop site.
fund compare tool image
Fund Compare
Quickly evaluate different MFs, CEFs and ETFs against one another
portfolio review tool image
Portfolio Review
Generate a detailed analysis of your portfolio holdings including MFs, CEFs and ETFs
Image of Municipal bond investing ladder tool
Municipal Bond Ladder Tool
Learn how a laddered portfolio may perform in rising rate environments
Powered by Morning star
Welcome to Nuveen
Select your preferred site so we can tailor your experience.
Select Region...
  • Americas
  • Asia Pacific
  • Europe, Middle East, Africa
location select
Select Location...
  • Canada
  • Latin America
  • United States
  • Australia
  • Hong Kong
  • Japan
  • Mainland China
  • Malaysia
  • New Zealand
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Other
  • Abu Dhabi Global Market (ADGM)
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • Other
location select
Global Cities REIT (GCREIT)
  • Institutional Investor
  • Individual Investor
  • Financial Professional
  • Global Cities REIT (GCREIT)
  • Green Capital
  • Private Capital Income Fund (PCAP)
location select
background-Pacific Center | Properties

Pacific Center

Side view with a sunset background

10455 Pacific Center Court is a healthcare R&D office building totaling 92,477 sf located in the Sorrento Mesa submarket of the San Diego MSA. The property is currently 100% leased to a leading medical device maker on a long-term lease. The investment supports GCREIT’s strategic goal of increasing its allocation to the health care sector and provides exposure to San Diego, a leading life science market.

The long-term impact on space demand caused by the work-from-home model, which COVID accelerated, is largely unknown in the health care sector. We have increased our allocation to medical office, life science, and R&D because we believe these alternative office uses are much more insulated from work-from-home solutions.”

-Richard Kimble, Portfolio Manager

Further information

The asset underwent a significant renovation and investment to transform the property into best in class R&D office, including lab space.

The property is leased through August 2028 to a top US medical device manufacturer which specializes in the commercialization of continuous glucose monitoring systems that are sold directly to people with diabetes and healthcare providers. The tenant has a major presence in the submarket with 788,000 sq. ft. across seven buildings in Sorrento Mesa. The Sorrento Mesa health-tech market is expected to continue growing, due to supply shortage, as well as, the increasing demand for lab and highly reusable clean room space.

The asset is ideally situated the heart of the Sorrento Mesa submarket of San Diego, one of the most sought-after real estate submarkets in Southern California due to the expanding life science concentration, highly diverse set of headquarter occupiers, and emerging technology companies.

Featured content

Sego Lily, GCREIT holding
Explore our global property portfolio

The properties pictured in the presentation represent select holdings at the time of publication and are not meant to represent the entire portfolio. The opinions expressed are reflective of the manager's views at the time of acquisition.

Contact us
Contact us
Back to Top